Bicara Therapeutics (BCAX) stock valuation

$9.21 Nov 18, 2026 · market cap $504B

7/121 investors
i

Bicara Therapeutics trades at $9.21. We don't have a valuation for it yet.

7 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate BCAXCreate free account →

Full open-source research report for BCAX on DeepValues Research (CC BY 4.0)